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Cellular plasticity has become the subject of intense research, with perhaps the greatest example provided by the recent Nobel Prize winners Drs. Yamananka and Gurdon and the demonstration that "terminally differentiated" fibroblasts can be coaxed into assuming an embryonic stem celllike fate. Emerging evidence suggests that plasticity inherent in cells may be hijacked in the progression of disease and cancer. However, the mechanisms by which cells acquire and regulate this plasticity remains incompletely understood. It is appreciated that broad programs must be unleashed during these switches, and, therefore, control at the epigenetic level in regulating these processes has garnered significant interest. In this issue of Circulation, Liu et al provide evidence implicating the epigenetic factor termed ten-eleven translocation-2 (TET2) in control of vascular smooth muscle cell (VSMC) plasticity and development of vascular disease. 1 Under homeostatic conditions, the principal function of the VSMC is regulation of vascular tone through the expression of unique contractile proteins, agonist receptors, and ion channels. 2 The differentiated "contractile" phenotype is characterized by the expression of cytoskeletal marker proteins including smooth muscle actin (ACTA2) and smooth musclemyosin heavy chain (MYH11). However, unlike other terminally differentiated muscle cell types (skeletal or cardiac), VSMC exhibit a high degree of phenotype plasticity. In response to injury or damage, VSMC assume a de-differentiated "synthetic" phenotype characterized by a high proliferative index, loss of contractile properties and proteins, and production of extracellular matrix products. This phenotype plasticity, first described by Chamley-Campbell and colleagues over 3 decades ago, 3 is observed both in vitro and in vivo in response to various environmental cues. 2 While this characteristic response is likely adaptive, an exaggerated response can contribute to the development / progression of vascular disease states such as stent restenosis or atherosclerosis. 4, 5 Thus, VSMC is an excellent cell type to study mechanisms mooth muscle cell (VSMC) plasticity and development of vascular disease. 1 Under homeostatic conditions, the principal function of the VSMC is regulation of va asc sc cul ul ula ar ar t t ton on one e thro ro rou ug ugh the expression of unique c c con on o t tractile proteins ns n , ag agon on onis i t receptors, and ion h ch han n annels. 2 Myocardin (MYOCD). 6, 7 Transcriptional regulation of these markers of differentiation is correlated to the phenotypic state of the VSMC; high expression of differentiation proteins correlating to a contractile phenotype, while proliferating VSMC are characterized by reduced levels of these differentiation proteins. 8 In the current issue of Circulation, Liu and colleagues advance our understanding and demonstrate that reversible VSMC differentiation is orchestrated through a mechanism involving the epigenetic DNA modifying enzyme TET2. 1 The TET proteins (TET 1-3) are DNA demethylases that oxidize 5-methylcytosine (5-mC) and generate 5-hydroxymethylcytosine (5-hmC). 9 TET proteins have been implicated in maintaining embryonic stem cell pluripotency while mutations are associated with hematopoietic disorders. However, a role for the TET family of proteins in regulating adult somatic cells, in particular VSMC, has not been studied extensively. Bearing this in mind, Liu and colleagues first established that TET2 was the most highly expressed TET isoform both in human coronary artery VSMC and in rapamycin-induced differentiated VSMC. Notably, TET2 expression directly correlated with VSMC differentiation markers including MYH11 and ACTA2. Further, Myocardin (MYOCD). 6, 7 Transcriptional regulation of these markers of different nt tia ati ti t on on n i i is s s correlated to the phenotypic state of the VSMC; high expression of differentiation proteins co orr rr rel el elat at ati in ing g g to t to a c c con on ontr t actile phenotype, while prol ol olif if i e erating VSMC C a a are c cha ha hara r cterized by reduced e eve e els l of these e di di diff f fere ren nt n ia ia iati ti tion on on p p pro rote te tein in ins. 8 by differentially de-methylating DNA at critical loci (Figure 1) .
DNA methylation typically occurs at the C5 position of cytosine (5-mC) in CpG dinucleotides and historically has been considered a stable epigenetic modification. However, the current work adds to a growing body of evidence that DNA methylation is a critical mechanism for dynamic regulation of gene expression (activation and repression), cellular phenotype, and function. DNA methylation is facilitated by DNA methlytransferase 3a and 3b (DNMT), while DNMT1 has been found to reinforce existing methylation patterns. However, it was recently discovered that the TET family of proteins promotes DNA demethylation through the conversion of 5-mC to 5-hmC as well as 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC). 10 In sum, the current work provides evidence that TET2 is instrumental in balancing the contractile/differentiated and synthetic/de-differentiated smooth muscle phenotype, two phenotypes with distinct molecular states. These provocative findings raise a number of interesting questions for vascular biology and, more broadly, the field of epigenetic control.
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